A team of medical researchers and doctors affiliated with several universities and two hospitals in the U.S. reports that administration of vitamin D2 to patients newly diagnosed with diabetes type 1 can prolong the so-called ...
A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of ...
Dec 10, 2022
0
4455
A new study by a University of Arkansas information systems researcher and his colleague at the University of Waikato in New Zealand shows that COVID vaccine trials conducted in geographic locations with low infection rates ...
May 24, 2022
0
105
A Phase 1 clinical trial conducted by University of Minnesota researchers has demonstrated the safety and efficacy of a novel immunotherapy drug in the treatment of human immunodeficiency virus (HIV). Results of the trial ...
Feb 1, 2022
0
65
Behind the chubby cheeks and bright eyes of babies as young as 8 months lies the smoothly whirring mind of a social statistician, logging our every move and making odds on what a person is most likely to do next, suggests ...
Jul 27, 2017
1
694
The world of Alzheimer's treatments is at an inflection point as more potential drugs make their way out of clinical trials.
Apr 24, 2024
0
0
Clinical trials for cancer drugs have three stages, Phase I–III, before marketing, each with different evaluation items. However, there is no consensus on the appropriateness of evaluation criteria for early-stage clinical ...
Apr 8, 2024
0
0
New guidelines have been developed to help researchers ensure that their clinical trial protocols and reports are complete, high-quality and transparent. Increased consistency across these documents will facilitate comparisons ...
Oct 20, 2023
0
1
The U.S. Food and Drug Administration has approved Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic atrophy secondary to age-related macular degeneration.
Aug 10, 2023
0
2
Two phase 3 trials suggest that a 16 week treatment with a drug called lebrikizumab was effective in adults and adolescents with moderate to severe dermatitis, according to a paper published in the New England Journal of ...
Mar 15, 2023
0
23
